Inventor
Daniel J. Ford
Inventor
San Francisco, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes18%
C07DHeterocyclic compounds16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
A61BDiagnosis13%
A01KAnimal husbandry8%
Y02ATechnologies for adaptation to climate change6%
G06KGraphical data reading5%
A61DVeterinary instruments, implements, tools, or methods3%
G06TImage data processing or generation, in general3%
G06VImage or video recognition or understanding3%
PatentTitleYear
11,109,801Method of measuring efficacy of treatment for an autoimmune disease in vivarium animals2021RE048622Therapeutically active pyrazolo-pyrimidine derivatives202111,033,494Apparatuses containing an emulsion and methods of manufacture202111,020,396Pyrimidinone derivatives as Cdc7 inhibitors202110,789,432Tracklets202010,596,198Devices for selectively releasing volatile compounds202010,568,567Method of drug approval using motion vector analysis202010,506,986Method of predicting severity of multiple sclerosis201910,420,503Method of measuring efficacy of treatment for multiple sclerosis201910,275,686Method of reading arbitrary symbols201910,244,979Method of early detection of multiple sclerosis201910,188,321Method of measuring animal health using motion vector analysis201910,176,397Method of reading degraded symbols201910,087,180Pyrazolo-pyridine derivatives as kinase inhibitors20189,969,748Fused bicyclic heteroaromatic derivatives as kinase inhibitors20189,714,248'Therapeutically active pyrazolo-pyrimidine derivatives'20179,700,257'Method of measuring gut transit time in animals'20179,382,263'Therapeutically active oxazoline derivatives'20169,227,984'Therapeutically active fused pyrimidine derivatives'20169,126,979'Compounds for inhibiting the interaction of BCL2 with binding partners'20159,096,614'Therapeutically active thiazolo-pyrimidine derivatives'20159,029,392'Quinoline derivatives as kinase inhibitors'20158,423,517'System and method for determining the age of objects in the presence of unreliable clocks'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2021Patents assigned to UNIV LEUVEN KATH (7)· patent assignee history
2015–2017Patents assigned to UCB PHARMA SA (4)· patent assignee history
2015–2016Patents assigned to BROOKINGS DANIEL CHRISTOPHER (2)· patent assignee history
2015–2021Based in Slough, GB· patent location history
2015Based in Windsor, GB· patent location history
2016–2021Patents assigned to UCB BIOPHARMA SPRL (4)· patent assignee history
2017–2021Patents assigned to VIUM INC (11)· patent assignee history
2017–2021Based in San Francisco, CA, US· patent location history
2019–2021Based in Belmont, CA, US· patent location history
2021Based in Sydney, AU· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VIUM INC | 11 | 2017–2021 |
| UNIV LEUVEN KATH | 7 | 2015–2021 |
| UCB BIOPHARMA SPRL | 4 | 2016–2021 |
| UCB PHARMA SA | 4 | 2015–2017 |
| BROOKINGS DANIEL CHRISTOPHER | 2 | 2015–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 9 | 2017–2021 |
| Slough, GB | 8 | 2015–2021 |
| Belmont, California, US | 3 | 2019–2021 |
| Sydney, AU | 1 | 2021 |
| Windsor, GB | 1 | 2015 |